Want to see RBOT full AI Analyst Report?

Vicarious Surgical (RBOT) Price & Analysis

261 Followers

RBOT Stock Chart & Stats

$0.11

>-$0.01(-1.26%)

At close: Jul 24 4:00 PM EDT

$0.11

>-$0.01(-1.26%)

Day’s Range― - ―

52-Week Range$0.04 - $7.72

Previous CloseN/A

Volume67.87K

Average Volume (3M)90.39K

Market Cap

$303.08K

Enterprise Value$8.64

Total Cash (Recent Filing)$3.68M

Total Debt (Recent Filing)$7.20M

Price to Earnings (P/E)―

Beta2.13

Next Earnings

Nov 17, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-6.75

Shares Outstanding6,477,365

10 Day Avg. Volume138,739

30 Day Avg. Volume90,387

Financial Highlights & Ratios

PEG Ratio0.01

Price to Book (P/B)1.31

Price to Sales (P/S)0.00

P/FCF Ratio-0.29

Enterprise Value/Market Cap<0.01

Enterprise Value/RevenueN/A

Enterprise Value/Gross Profit>-0.01

Enterprise Value/Ebitda>-0.01

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)-4.07

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Commercialization MilestoneTarget to deliver a design-frozen, production-equivalent system with required commercialization features by year-end 2026 could materially de-risk the path to market.

Risk-reducing Execution ShiftRefocusing on achieving design freeze rather than pursuing an earlier clinical start reduces technical and regulatory execution risk and clarifies operational priorities.

Strategic OutsourcingPlanned partnership with a consultant to outsource certain components aims to reduce cash burn and sharpen focus on proprietary technology development.

Bears Say

Analyst SentimentAnalyst's neutral recommendation reflects delays in product development and a challenging macroeconomic backdrop, suggesting investors may prefer to wait for clearer progress.

Capital Runway RiskAnalysts warn the company may exhaust cash by early fiscal 2026 without significant cuts to cash burn or new financing, creating funding pressure for continued development.

Extended Development TimelineDesign freeze timeline extended to the end of fiscal 2026 from a mid-fiscal 2026 target, increasing uncertainty on product readiness and launch timing.

Vicarious Surgical News

Vicarious Surgical Approves Liquidation and Dissolution Plan

The latest announcement is out from Vicarious Surgical ( ($RBOT) ). On July 21, 2026, Vicarious Surgical’s stockholders...

30d ago

RBOT

SS Innovations appoints Sarah Romano as CFO

SS Innovations (SSII) announced the appointment of Sarah Romano as CFO, effective August 3. Romano will be based...

1M ago

RBOT

SSII

Vicarious Surgical Announces Upcoming Chief Financial Officer Resignation

The latest announcement is out from Vicarious Surgical ( ($RBOT) ). On June 24, 2026, Vicarious Surgical disclosed...

2M ago

RBOT

Vicarious Surgical Shareholders Approve Reverse Stock Split Authorization

Vicarious Surgical ( ($RBOT) ) has issued an announcement. On April 8, 2026, Vicarious Surgical Inc. held a...

4M ago

RBOT

Vicarious Surgical announces plan to pursue Nasdaq listing

Vicarious Surgical (RBOT) announced a series of strategic actions to support a potential relisting of its common stock...

5M ago

RBOT

Vicarious Surgical Delisted to OTC as Losses Narrow

Vicarious Surgical ( ($RBOT) ) has provided an announcement. On March 3, 2026, the New York Stock Exchange...

5M ago

RBOT

Vicarious Surgical Implements Executive Salary Reductions, Maintains Incentives

The latest update is out from Vicarious Surgical ( ($RBOT) ). On March 4, 2026, Vicarious Surgical Inc....

6M ago

RBOT

Vicarious Surgical Announces NYSE Delisting and OTC Transition

Vicarious Surgical ( ($RBOT) ) has shared an announcement. On March 3, 2026, Vicarious Surgical received notice that...

6M ago

RBOT

Vicarious Surgical receives delisting notice from NYSE

Vicarious Surgical (RBOT) announced that it received a notice from the NYSE that the NYSE has commenced the...

6M ago

RBOT

NYSE to begin delisting procedures against Vicarious Surgical

The New York Stock Exchange announced that it will commence delisting procedures against Vicarious Surgical (RBOT). Published first...

6M ago

RBOT

Vicarious Surgical Enhances CEO and CFO Severance Protections

Vicarious Surgical ( ($RBOT) ) has provided an announcement. On February 2, 2026, Vicarious Surgical Inc. amended the...

7M ago

RBOT

Vicarious Surgical Stockholders Approve Warrant Exercise Proposal

Vicarious Surgical ( ($RBOT) ) just unveiled an update. On January 9, 2026, Vicarious Surgical Inc. held a...

7M ago

RBOT

Vicarious Surgical announces software partnership to streamline operations

Vicarious Surgical (RBOT) announced that it has entered into a strategic partnership agreement with a global digital engineering...

8M ago

RBOT

Vicarious Surgical Announces 2026 Cash Burn Guidance

Vicarious Surgical ( ($RBOT) ) just unveiled an update. On December 12, 2025, Vicarious Surgical Inc. entered into...

8M ago

RBOT

RBOT FAQ

What was Vicarious Surgical’s price range in the past 12 months?

Vicarious Surgical lowest stock price was $0.04 and its highest was $7.72 in the past 12 months.

What is Vicarious Surgical’s market cap?

Vicarious Surgical’s market cap is $303.08K.

When is Vicarious Surgical’s upcoming earnings report date?

Vicarious Surgical’s upcoming earnings report date is Nov 17, 2026 which is in 89 days.

How were Vicarious Surgical’s earnings last quarter?

Currently, no data Available

Is Vicarious Surgical overvalued?

According to Wall Street analysts Vicarious Surgical’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Vicarious Surgical pay dividends?

Vicarious Surgical does not currently pay dividends.

What is Vicarious Surgical’s EPS estimate?

Vicarious Surgical’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Vicarious Surgical have?

Vicarious Surgical has 6,477,365 shares outstanding.

What happened to Vicarious Surgical’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Vicarious Surgical?

Currently, no hedge funds are holding shares in RBOT

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Vicarious Surgical

Vicarious Surgical Inc. is dedicated to the development and commercialization of advanced single-incision surgical robotics. Their innovative technology is designed to give surgeons a virtual, immersive presence within the patient's body, facilitating highly precise and minimally invasive operations. The company's primary product, the Vicarious System, is a sophisticated single-incision robot engineered specifically for procedures like ventral hernia repair. Established in 2014, Vicarious Surgical Inc. operates from its corporate headquarters in Waltham, Massachusetts.